Matrix metalloproteinases as modulators of inflammation.
暂无分享,去创建一个
[1] M. Rojas,et al. Selective Ablation of Matrix Metalloproteinase-2 Exacerbates Experimental Colitis: Contrasting Role of Gelatinases in the Pathogenesis of Colitis1 , 2006, The Journal of Immunology.
[2] M. Schwartz,et al. Matrix metalloproteinase inhibitors as prospective agents for the prevention and treatment of cardiovascular and neoplastic diseases. , 2006, Current topics in medicinal chemistry.
[3] J. Wallace,et al. Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. , 2002, Blood.
[4] Takashi Ishikawa,et al. Matrilysin (MMP-7) degrades VE-cadherin and accelerates accumulation of beta-catenin in the nucleus of human umbilical vein endothelial cells. , 2006, Oncology reports.
[5] G. Schuler,et al. Matrix Metalloproteinases 9 and 2 Are Necessary for the Migration of Langerhans Cells and Dermal Dendritic Cells from Human and Murine Skin1 , 2002, The Journal of Immunology.
[6] W. Parks,et al. Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium. , 2003, The American journal of pathology.
[7] C. Blobel,et al. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). , 2001, The Journal of biological chemistry.
[8] Christopher M Overall,et al. Proteomics Discovery of Metalloproteinase Substrates in the Cellular Context by iTRAQ™ Labeling Reveals a Diverse MMP-2 Substrate Degradome*S , 2007, Molecular & Cellular Proteomics.
[9] J. Madri,et al. MMP‐2 null mice exhibit an early onset and severe experimental autoimmune encephalomyelitis due to an increase in MMP‐9 expression and activity , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[10] T. K. Hunt,et al. Impaired wound contraction in stromelysin-1-deficient mice. , 1999, Annals of surgery.
[11] M. Stack,et al. Membrane protease proteomics: Isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[12] William C. Parks,et al. The Activity of Collagenase-1 Is Required for Keratinocyte Migration on a Type I Collagen Matrix , 1997, The Journal of cell biology.
[13] Shigeyoshi Itohara,et al. The Role of Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 in Antibody-Induced Arthritis , 2002, The Journal of Immunology.
[14] M. Milla,et al. The tumor necrosis factor-alpha converting enzyme (TACE): a unique metalloproteinase with highly defined substrate selectivity. , 2002, Biochemistry.
[15] E. Reinke,et al. Dendritic Cell Transmigration through Brain Microvessel Endothelium Is Regulated by MIP-1α Chemokine and Matrix Metalloproteinases1 , 2007, The Journal of Immunology.
[16] A. Gaggar,et al. Matrix Metalloproteinase 9 Activity Enhances Host Susceptibility to Pulmonary Infection with Type A and B Strains of Francisella tularensis1 , 2007, The Journal of Immunology.
[17] G. Opdenakker,et al. Gelatinase B deficiency protects against endotoxin shock , 2002, European journal of immunology.
[18] J. Varani,et al. The role of metalloelastase in immune complex-induced acute lung injury. , 2001, The American journal of pathology.
[19] J. Mudgett,et al. Susceptibility of stromelysin 1-deficient mice to collagen-induced arthritis and cartilage destruction. , 1998, Arthritis and rheumatism.
[20] F. Lupu,et al. Persistence of Atherosclerotic Plaque but Reduced Aneurysm Formation in Mice With Stromelysin-1 (MMP-3) Gene Inactivation , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[21] G. Müller,et al. Proinflammatory role of fractalkine (CX3CL1) in rheumatoid arthritis. , 2003, The Journal of rheumatology.
[22] M. Lambert,et al. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α , 1997, Nature.
[23] S. Husson,et al. Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities. , 2003, European journal of biochemistry.
[24] M. Götte,et al. Functions of cell surface heparan sulfate proteoglycans. , 1999, Annual review of biochemistry.
[25] D. Missé,et al. Dengue‐virus‐infected dendritic cells trigger vascular leakage through metalloproteinase overproduction , 2006, EMBO reports.
[26] G. Rosenberg. Matrix metalloproteinases in neuroinflammation , 2002, Glia.
[27] L. Matrisian,et al. Osteopontin, a Novel Substrate for Matrix Metalloproteinase-3 (Stromelysin-1) and Matrix Metalloproteinase-7 (Matrilysin)* , 2001, The Journal of Biological Chemistry.
[28] C. Overall. Molecular determinants of metalloproteinase substrate specificity , 2002, Molecular biotechnology.
[29] L. Matrisian,et al. Matrilysin expression and function in airway epithelium. , 1998, The Journal of clinical investigation.
[30] G. Gorodeski. Estrogen decrease in tight junctional resistance involves matrix-metalloproteinase-7-mediated remodeling of occludin. , 2007, Endocrinology.
[31] C. López-Otín,et al. Loss of collagenase-2 confers increased skin tumor susceptibility to male mice , 2003, Nature Genetics.
[32] K. Sunagawa,et al. Selective disruption of MMP-2 gene exacerbates myocardial inflammation and dysfunction in mice with cytokine-induced cardiomyopathy. , 2005, American journal of physiology. Heart and circulatory physiology.
[33] M. Rojas,et al. Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: central role of epithelial-derived MMP. , 2005, Gastroenterology.
[34] D. Brenner,et al. Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis , 2006, Hepatology.
[35] Nicole Nelson,et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells , 1997, Nature.
[36] G. Rosenberg,et al. Blood–brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation , 2006, Neurobiology of Disease.
[37] A. Churg,et al. Macrophage metalloelastase mediates acute cigarette smoke-induced inflammation via tumor necrosis factor-alpha release. , 2003, American journal of respiratory and critical care medicine.
[38] R. W. Rauser,et al. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[39] G. Dougan,et al. Impaired Immunity to Intestinal Bacterial Infection in Stromelysin-1 (Matrix Metalloproteinase-3)-Deficient Mice1 , 2004, The Journal of Immunology.
[40] R. Sciot,et al. Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions. , 1999, The Journal of clinical investigation.
[41] R. Pauwels,et al. Matrix metalloproteinase-9 deficiency impairs cellular infiltration and bronchial hyperresponsiveness during allergen-induced airway inflammation. , 2002, The American journal of pathology.
[42] Shigeyoshi Itohara,et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis , 2000, Nature Cell Biology.
[43] Y. Sasaguri,et al. Degradation of Interleukin 1β by Matrix Metalloproteinases* , 1996, The Journal of Biological Chemistry.
[44] T. Yoshizaki,et al. Cleavage of Syndecan-1 by Membrane Type Matrix Metalloproteinase-1 Stimulates Cell Migration* , 2003, Journal of Biological Chemistry.
[45] William C. Parks,et al. Matrilysin Shedding of Syndecan-1 Regulates Chemokine Mobilization and Transepithelial Efflux of Neutrophils in Acute Lung Injury , 2002, Cell.
[46] S. Shapiro,et al. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. , 1997, Science.
[47] B. Ma,et al. Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling. , 2002, The Journal of clinical investigation.
[48] B. Fingleton,et al. Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption. , 2000, The Journal of clinical investigation.
[49] J. Friedland,et al. The paradox of matrix metalloproteinases in infectious disease , 2005, Clinical and experimental immunology.
[50] I. Stamenkovic,et al. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. , 2000, Genes & development.
[51] Carlos López-Otín,et al. The FASEB Journal • Research Communication Increased inflammation delays wound healing in mice deficient in collagenase-2 (MMP-8) , 2022 .
[52] Z. Werb,et al. Proteomic Identification of In Vivo Substrates for Matrix Metalloproteinases 2 and 9 Reveals a Mechanism for Resolution of Inflammation1 , 2006, The Journal of Immunology.
[53] L. Matrisian,et al. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. , 1999, Science.
[54] B. Boyan,et al. Activation of Latent Transforming Growth Factor β1 by Stromelysin 1 in Extracts of Growth Plate Chondrocyte‐Derived Matrix Vesicles , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[55] William C. Parks,et al. Matrix metalloproteinases as modulators of inflammation and innate immunity , 2004, Nature Reviews Immunology.
[56] Changlian Zhu,et al. Matrix Metalloproteinase-9 Gene Knock-out Protects the Immature Brain after Cerebral Hypoxia–Ischemia , 2007, The Journal of Neuroscience.
[57] A. Noël,et al. Resistance of Collagenase-2 (Matrix Metalloproteinase-8)-Deficient Mice to TNF-Induced Lethal Hepatitis1 , 2005, The Journal of Immunology.
[58] P. McGuire,et al. Proteolytic Degradation of VE-Cadherin Alters the Blood-Retinal Barrier in Diabetes , 2007, Diabetes.
[59] C. Overall,et al. Discovery of Chemokine Substrates for Matrix Metalloproteinases by Exosite Scanning: A New Tool for Degradomics , 2002, Biological chemistry.
[60] B. Rossi,et al. Soluble Fractalkine Prevents Monocyte Chemoattractant Protein-1-Induced Monocyte Migration via Inhibition of Stress-Activated Protein Kinase 2/p38 and Matrix Metalloproteinase Activities1 , 2004, The Journal of Immunology.
[61] X. Puente,et al. Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors , 2004, Biological chemistry.
[62] C. López-Otín,et al. Membrane-Bound Matrix Metalloproteinase-8 on Activated Polymorphonuclear Cells Is a Potent, Tissue Inhibitor of Metalloproteinase-Resistant Collagenase and Serpinase1 , 2004, The Journal of Immunology.
[63] S. Nourshargh,et al. Matrix Metalloproteinase-9 Deficiency Results in Enhanced Allergen-Induced Airway Inflammation1 , 2004, The Journal of Immunology.
[64] C. Dijkstra,et al. Diapedesis of monocytes is associated with MMP‐ mediated occludin disappearance in brain endothelial cells , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[65] Z. Werb,et al. Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency , 2002, Nature Immunology.
[66] P. E. Van den Steen,et al. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. , 2000, Blood.
[67] F. Fahrenholz,et al. The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. , 2003, Blood.
[68] A. Luttun,et al. Loss of Matrix Metalloproteinase-9 or Matrix Metalloproteinase-12 Protects Apolipoprotein E–Deficient Mice Against Atherosclerotic Media Destruction but Differentially Affects Plaque Growth , 2004, Circulation.
[69] V. Wee Yong,et al. An Adverse Role for Matrix Metalloproteinase 12 after Spinal Cord Injury in Mice , 2003, The Journal of Neuroscience.
[70] P. Libby,et al. Generation of Biologically Active IL-1β by Matrix Metalloproteinases: A Novel Caspase-1-Independent Pathway of IL-1β Processing , 1998, The Journal of Immunology.
[71] B. Fingleton,et al. Matrix metalloproteinase-3-dependent generation of a macrophage chemoattractant in a model of herniated disc resorption. , 2000, The Journal of clinical investigation.
[72] X. Puente,et al. Membrane Type 4 Matrix Metalloproteinase (MMP17) Has Tumor Necrosis Factor-α Convertase Activity but Does Not Activate Pro-MMP2* , 2000, The Journal of Biological Chemistry.
[73] J. Mudgett,et al. Matrix metalloproteinase deficiencies affect contact hypersensitivity: stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[74] C. Overall,et al. Matrix Metalloproteinase Activity Inactivates the CXC Chemokine Stromal Cell-derived Factor-1* , 2001, The Journal of Biological Chemistry.
[75] B. Boyan,et al. The First Stage of Transforming Growth Factor β1 Activation is Release of the Large Latent Complex from the Extracellular Matrix of Growth Plate Chondrocytes by Matrix Vesicle Stromelysin-1 (MMP-3) , 2001, Calcified Tissue International.
[76] Cheng S. Lee,et al. Recent advances in capillary separations for proteomics , 2004, Electrophoresis.
[77] Z. Werb,et al. Overlapping and independent contributions of MMP2 and MMP9 to lung allergic inflammatory cell egression through decreased CC chemokines , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[78] George Kollias,et al. The function of tumour necrosis factor and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease , 1999, Annals of the rheumatic diseases.
[79] S. Weiss,et al. Role of stromelysin 1 and gelatinase B in experimental acute lung injury. , 2001, American Journal of Respiratory Cell and Molecular Biology.
[80] T. Ley,et al. Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[81] T. van der Poll,et al. Matrix Metalloproteinase-9 Deficiency Impairs Host Defense against Abdominal Sepsis1 , 2006, The Journal of Immunology.
[82] Z. Werb,et al. The Serpin α1-Proteinase Inhibitor Is a Critical Substrate for Gelatinase B/MMP-9 In Vivo , 2000, Cell.
[83] A. Kraneveld,et al. A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation , 2006, Nature Medicine.
[84] C. Overall,et al. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. , 2000, Science.
[85] Elias Lolis,et al. Structure, function, and inhibition of chemokines. , 2002, Annual review of pharmacology and toxicology.